Embecta Corp. (NASDAQ: EMBC) was unchanged Tuesday, as the global diabetes care company with a 100-year legacy in insulin delivery announced a new landmark publication in the Mayo Clinic Proceedings.
("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new ...
Strategic Expansion into Global Travel Industry. NEW YORK, NY , April 01, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited ...
In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...